DCF — DANVILLE REGIONAL MEDICAL CENTER
Enterprise Value: $181.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$181.9M
Enterprise Value
$44.6M
PV of Cash Flows
$137.3M
PV of Terminal Value
$221.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $362.6M | $26.6M | 7.0% | $6.9M | $6.3M |
| Year 2 | $373.5M | $31.2M | 8.0% | $9.9M | $8.2M |
| Year 3 | $384.7M | $36.0M | 9.0% | $13.1M | $9.8M |
| Year 4 | $396.3M | $39.0M | 10.0% | $15.0M | $10.2M |
| Year 5 | $408.2M | $41.2M | 10.0% | $16.2M | $10.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $181.9M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$352.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06846506606604741
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5